STOCK TITAN

Anterix legal chief sells 4,357 shares at $85.44

Anterix Inc. (ATEX) reported that Chief Legal Officer and Corporate Secretary Gena L. Ashe sold an aggregate of 4,357 shares of Anterix common stock on September 8, 2026, in two open-market or private transactions at $85.44 per share.

(Moderate)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Anterix Inc. (ATEX) reported that Chief Legal Officer and Corporate Secretary Gena L. Ashe sold an aggregate of 4,357 shares of Anterix common stock on September 8, 2026, in two open-market or private transactions at $85.44 per share. No Rule 10b5-1 trading plan is reported for these sales.

Positive

  • None.

Negative

  • None.
Insider Ashe Gena L
Role Chief Legal Officer & Corp Sec
Sold 4,357 shs ($372K)
Type Security Shares Price Value
Sale Common Stock 293 $85.44 $25K
Sale Common Stock 4,064 $85.44 $347K
Holdings After Transaction: Common Stock — 5,174 shares (Direct)
Shares sold (first transaction) 293 shares Sale of Anterix common stock on September 8, 2026
Shares sold (second transaction) 4,064 shares Sale of Anterix common stock on September 8, 2026
Total shares sold 4,357 shares Aggregate of two reported sales by Gena L. Ashe
Sale price per share $85.44 per share Price for both September 8, 2026 sales of Anterix common stock
Number of sale transactions 2 transactions Non-derivative open-market or private sales reported
open market or private transaction financial
"transaction described as a Sale in open market or private transaction"
Rule 10b5-1 plan regulatory
"no Rule 10b5-1 trading plan is reported for these sales"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
Common Stock financial
"security title identified as Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

What insider transaction did ATEX disclose for September 8, 2026?

Anterix Inc. disclosed that its Chief Legal Officer and Corporate Secretary, Gena L. Ashe, sold a total of 4,357 shares of Anterix common stock on September 8, 2026 in open-market or private transactions at $85.44 per share.

What price per share was received in the September 8, 2026 ATEX insider sales?

Each sale of Anterix Inc. (ATEX) common stock reported by Gena L. Ashe on September 8, 2026 was executed at $85.44 per share, according to the Form 4 disclosure.

Were the September 8, 2026 ATEX insider sales under a Rule 10b5-1 plan?

No. The Form 4 for Anterix Inc. indicates the Rule 10b5-1 checkbox is not marked, so no Rule 10b5-1 trading plan is reported in connection with these September 8, 2026 sales.

What role does the insider have at Anterix Inc. (ATEX)?

The reporting insider, Gena L. Ashe, is identified as Anterix Inc.’s Chief Legal Officer & Corporate Secretary on the Form 4 covering the September 8, 2026 stock sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ashe Gena L

(Last)(First)(Middle)
3 GARRET MOUNTAIN PLAZA
SUITE 401

(Street)
WOODLAND PARK NEW JERSEY 07424

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Anterix Inc. [ ATEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Legal Officer & Corp Sec
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/08/2026S293D$85.449,238D
Common Stock09/08/2026S4,064D$85.445,174D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Gena L. Ashe09/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading